Scott Wolchko To Retire as President and CEO after 10 years of Leadership in Pioneering iPSC-derived Cellular Immunotherapies SAN DIEGO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc.
By David Doe FIERGBOR Insurtech firms are crucial in expanding insurance coverage, particularly for underserved populations. Compared to traditional insurers, these agile firms leverage technology to ...